3 chapters across the catalog
Medical Care, Placebo Biology, Pharmaceutical Skepticism
The hosts expand on the ketamine study to discuss the broader implications of the placebo effect in modern medicine. They argue that many psychiatric drugs, such as Zoloft and Xanax, may rely on the patient's belief in the medication rather than chemical efficacy. The segment emphasizes that the placebo effect has real biological foundations and should be considered a valid medical tool.
A new study explores the use of intravenous ketamine as a treatment for severe depression that does not respond to traditional medications. The hosts contrast this with a listener's negative experience with Zoloft, which reportedly caused increased anger and personality changes. They question the accessibility of ketamine treatments and the prevalence of antidepressant prescriptions in modern medicine.
A former Pfizer pharmaceutical representative claims that Zoloft was known to increase the incidence of suicide attempts during the initial phase of treatment. The discussion connects the use of psychotropic drugs and SSRIs to the behavior of school shooters, noting a lack of media investigation into the medication history of perpetrators.
